# Turn Biotechnologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/turn-biotechnologies

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.turn.bio
- Latest round: Seed (Aug 26, 2019)
- Investors on record: 2

## About

Turn Biotechnologies, Inc., based in the US, focuses on developing innovative therapies aimed at reversing age-related diseases through epigenetic reprogramming and cellular restoration.Founded in 2018 in San Francisco, US, Turn Biotechnologies specializes in epigenetic therapies for age-related cellular dysfunction. The company's latest funding round was a Series A that raised USD 29.13 mn, bringing the total amount raised to USD 29.13 mn. The company's valuation stands at USD 40.63 mn. The founders include Marco Quarta, Sergio Ruiz, and Vittorio Sebastiano, while Anja Krammer serves as CEO.Turn Biotechnologies specializes in developing epigenetic reprogramming therapies designed to combat age-related diseases and restore cellular function. Their flagship product, the Epigenetic Reprogramming of Age (ERA™), employs proprietary mRNA cocktails to enhance cell vitality and target specific tissues. Their clientele includes research institutions and healthcare providers seeking to address age-related conditions across North America, Europe, and Asia.Turn Biotechnologies generates revenue through partnerships and collaborations with research institutions and healthcare organizations, providing access to its ERA™ therapies. Revenue streams include licensing agreements for its proprietary technology and collaborative research and development efforts. Pricing structures are customized to meet client needs, reflecting the tailored nature of their services.Following the Series A funding round that raised USD 29.13 mn on August 22, 2023, Turn Biotechnologies plans to leverage these funds to advance the development of new epigenetic therapies and expand into major markets in Europe and Asia by 2025. The company aims to enhance its product offerings and broaden its reach in the healthcare sector, targeting additional research collaborations to support their cutting-edge technologies.

## Funding rounds

- Seed, Aug 26, 2019 — Formic Ventures
- Seed, Jun 6, 2019 — KIZOO Technology Ventures

## Investors

- KIZOO Technology Ventures (https://capitalatlas.ai/funds/kizoo-technology-ventures) — Seed
- Formic Ventures (https://capitalatlas.ai/funds/formic-ventures) — Seed